We are a U.S.-based biopharmaceutical company specializing in the commercialization of pharmaceutical products for the treatment of dermatological conditions, in particular, diseases caused primarily by exposure to sunlight that result in sun damage to the skin.
$5.00 - $7.00
October 29, 2021
ROTH CAPITAL PARTNERS, LLC
This offering is no longer available
Sign Up to participate in future offerings
To view the prospectus for Biofrontera Inc IPO, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277